News, events, and resources
Oct 14, 2026
Clinical Dose Optimization: From Phase 2 Dose Finding to FDA Project Optimus
Explore how PK–PD biomarkers, exposure–response modeling and fit-for-purpose bioanalysis support clinical dose optimization and FDA Project ...
Oct 12, 2026
18th Annual Immunogenicity & Bioassay Summit
Visit Crystal Bio Solutions at Booth #4, 18th Annual Immunogenicity & Bioassay Summit, to explore partnerships that advance biologics ...
Sep 14, 2026
How to Choose a CRO for ADC Bioanalysis
Learn how to evaluate a CRO for ADC bioanalysis: three-analyte PK coverage, subclass-specific total antibody methods, and hybrid LC-MS/MS ...
Sep 9, 2026
Meet CBS at OCT Southern California 2026
Connect with our bioanalysis, biomarker, and clinical pharmacology experts at Booth #67b to discuss development challenges and strategies ...
Aug 19, 2026
Crystal Bio Solutions Scientific Symposium & Reception
Join Bay Area biotech and biopharma leaders for the CBS Scientific Symposium & Reception, an afternoon of expert talks and executive ...
Jul 28, 2026
Population PK/PD Modeling That Starts With Better Bioanalysis
Discover how integrated bioanalysis, biomarkers, ADA assessment and Pop PK/PD modeling support Model-Informed Drug Development and biologic ...
Jul 14, 2026
Critical Quality Attributes in Antibody-Drug Conjugates
Learn the six critical quality attributes (CQAs) every ADC program should monitor and how analytical characterization supports successful ...
Jun 10, 2026
ADC Bioanalysis: DAR Profiling and Stability Analysis
Explore key strategies for ADC bioanalysis, including DAR characterization, payload stability, and LC-MS-based biotransformation studies.
Jun 3, 2026
Heading to BIO International Convention 2026 in San Diego?
Connect with Crystal Bio Solutions in San Diego to optimize your assay strategy, biomarkers, and regulatory compliance.
Jun 2, 2026
High-resolution Mass Spectrometry (HRMS) in Biologics Characterization
Discover how high-resolution mass spectrometry enhances biologics characterization, supporting critical analyses from peptide mapping to ...
Clinical Dose Optimization: From Phase 2 Dose Finding to FDA Project Optimus
Explore how PK–PD biomarkers, exposure–response modeling and fit-for-purpose bioanalysis support clinical dose optimization and FDA Project ...
How to Choose a CRO for ADC Bioanalysis
Learn how to evaluate a CRO for ADC bioanalysis: three-analyte PK coverage, subclass-specific total antibody methods, and hybrid LC-MS/MS ...
ADC Bioanalysis: DAR Profiling and Stability Analysis
Explore key strategies for ADC bioanalysis, including DAR characterization, payload stability, and LC-MS-based biotransformation studies.
High-resolution Mass Spectrometry (HRMS) in Biologics Characterization
Discover how high-resolution mass spectrometry enhances biologics characterization, supporting critical analyses from peptide mapping to ...
18th Annual Immunogenicity & Bioassay Summit
Visit Crystal Bio Solutions at Booth #4, 18th Annual Immunogenicity & Bioassay Summit, to explore partnerships that advance biologics ...
Meet CBS at OCT Southern California 2026
Connect with our bioanalysis, biomarker, and clinical pharmacology experts at Booth #67b to discuss development challenges and strategies ...
Crystal Bio Solutions Scientific Symposium & Reception
Join Bay Area biotech and biopharma leaders for the CBS Scientific Symposium & Reception, an afternoon of expert talks and executive ...
Heading to BIO International Convention 2026 in San Diego?
Connect with Crystal Bio Solutions in San Diego to optimize your assay strategy, biomarkers, and regulatory compliance.